MANAGING AROMATASE INHIBITOR-ASSOCIATED BONE LOSS: PRACTICAL GUIDANCE

被引：0
|
作者：
Hadji, P. [1 ]
Body, J. [2 ,3 ]
Aapro, M. [4 ]
Brufsky, A. [5 ]
Coleman, R. [6 ]
Guise, T. [7 ]
Lipton, A. [8 ]
Tubiana-Hulin, M. [9 ]
机构：
[1] Univ Marburg, Dept Gynecol, Marburg, Germany
[2] CHU Brugmann, Brussels, Belgium
[3] Inst Jules Bordet, ULB, B-1000 Brussels, Belgium
[4] Clin Genolier, Inst Multidisciplinaire Doncol, Genolier, Switzerland
[5] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
[6] Weston Pk Hosp, Canc Res Ctr, Sheffield, S Yorkshire, England
[7] Univ Virginia, Dept Med, Charlottesville, VA USA
[8] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[9] Ctr Rene Huguenin, St Cloud, France
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] Aromatase inhibitor-associated bone loss in breast cancer patients under adjuvant treatment with anastrozole: Experience of a centre
    Sales Fidalgo, P.
    Chaves, A.
    Pais, A.
    Neto, J.
    Pereira, J.
    Patricio, M.
    Jesus, E.
    Gervasio, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S55 - S55
  • [22] Getting a grip on aromatase inhibitor-associated arthralgias
    Hershman, Dawn L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) : 3120 - 3121
  • [23] Aromatase Inhibitor-Associated Musculoskeletal Symptoms #402
    Chang, Philip J.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2020, 23 (11) : 1542 - 1543
  • [24] Aromatase inhibitor-associated tenosynovitis: A new entity?
    Griffing, W. L.
    Mazlumzadeh, M.
    Harmon, C. E.
    Northfelt, D. W.
    Gornet, M. K.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S650 - S650
  • [25] Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics
    Liu, Mohan
    Goss, Paul E.
    Ingle, James N.
    Kubo, Michiaki
    Furukawa, Yoichi
    Batzler, Anthony
    Jenkins, Gregory D.
    Carlson, Erin E.
    Nakamura, Yusuke
    Schaid, Daniel J.
    Chapman, Judy-Anne W.
    Shepherd, Lois E.
    Ellis, Matthew J.
    Khosla, Sundeep
    Wang, Liewei
    Weinshilboum, Richard M.
    [J]. MOLECULAR ENDOCRINOLOGY, 2014, 28 (10) : 1740 - 1751
  • [26] Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
    Park, Jin Young
    Lee, Se Kyung
    Bee, Soo Youn
    Kim, Jiyoung
    Kim, Min Kuk
    Kil, Won Ho
    Lee, Jeong Eon
    Nam, Seok Jin
    [J]. JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2013, 85 (05): : 205 - 211
  • [27] Pain and Sensitization in Women with Aromatase Inhibitor-Associated Arthralgias
    Crespo-Bosque, Monica
    Brown, Carrie
    Cartmel, Brenda
    Harrigan, Maura
    Irwin, Melinda
    Neogi, Tuhina
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management
    Altundag, Kadri
    Dede, Didem
    Harputluoglu, Hakan
    Gullu, Ibrahim
    [J]. JOINT BONE SPINE, 2007, 74 (06) : 662 - 663
  • [29] Updated guidance for the prevention of aromatase inhibitor (AI)-associated bone loss (AIBL) in early breast cancer (EBC)
    Hadji, P.
    Body, J.
    Bundred, N.
    Brufsky, A.
    Coleman, R.
    Gnant, M.
    Guise, T.
    Lipton, A.
    Aapro, M.
    [J]. BREAST, 2011, 20 : S84 - S84
  • [30] Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
    Sun, Shengliang
    Wang, Fuchao
    Dou, Honglei
    Zhang, Longqiang
    Li, Jiwen
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 6029 - 6036
12345